BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
Seasoned executive brings more than three decades of immunotherapy and drug discovery experience PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) — BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive immunotherapy drug discovery and […]
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer Read More »